T
Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
NASDAQ:TLIS
Price:
9.15 USD
0.55%
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
The Relative Value of one TLIS stock under the Base Case scenario is 30.26 USD. Compared to the current market price of 9.15 USD, Talis Biomedical Corp is Undervalued by 70%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TLIS
Relative Value
Base Case
30.26
USD
Undervaluation 70%
T
Valuation Multiples
Multiples Across Competitors
TLIS Competitors Multiples
Talis Biomedical Corp Competitors
Talis Biomedical Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
16.6m USD | 7.6 | -0.2 | 1 | 0.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | 37.2 | 24.2 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | 60.5 | 30.8 | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.4 | 28.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | 79.5 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
